-
May 08, 2013
Amgen really needs the pipeline to come through to support this valuation.
-
February 14, 2013
Acorda Therapeutics Inc.'s (ACOR) fourth quarter earnings (including share-based compensation charges but excluding ...
-
February 11, 2013
Biogen Idec (BIIB) and partner, Swedish Orphan Biovitrum recently presented encouraging data on their hemophilia ...
-
February 07, 2013
Elan Corporation (ELN) reported earnings of 15 cents per share for the fourth quarter of 2012 compared to the ...
-
February 04, 2013
Elan Corporation plc (ELN) recently decided to sell its remaining 7.8 million ordinary shares in Alkermes plc (ALKS) ...
-
January 28, 2013
The busy economic and earnings calendar this week will give stocks a clear directional nudge after they reached ...
-
January 28, 2013
Monday, January 28, 2013 The busy economic and earnings calendar this week will give stocks a clear directional ...
-
January 28, 2013
Biogen Idec (BIIB) reported fourth quarter earnings per share of $1.40, missing the Zacks Consensus Estimate of ...
-
January 25, 2013
Biogen Idec (BIIB) recently announced positive top-line data on its phase III multiple sclerosis candidate, ...
-
January 17, 2013
Biogen Idec Inc. (BIIB) and partner Elan Corporation (ELN) recently submitted applications to the US Food and Drug ...
-
January 09, 2013
Alkermes plc (ALKS) recently reaffirmed its view for fiscal 2013 (ending March 31, 2013). The company continues to ...
-
January 08, 2013
Alnylam Pharmaceuticals Inc (ALNY) recently announced its goal for the next two years (2013 and 2014) regarding its ...
-
January 08, 2013
Biogen Idec (BIIB) recently submitted a Biologics License Application (BLA) seeking US Food and Drug Administration ...
-
January 03, 2013
This morning, the market has been relatively quiet. The Nasdaq remains relatively unchanged; the S&P 500 is ...
-
December 17, 2012
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recently did not ...
-
December 14, 2012
Isis Pharmaceuticals Inc. (ISIS) and AstraZeneca (AZN) recently announced that they have entered into an agreement ...
-
December 07, 2012
PDL BioPharma Inc. (PDLI) recently announced that it expects to generate fourth quarter 2012 royalty revenues of $86 ...
-
November 23, 2012
Sanofi (SNY) and its subsidiary Genzyme recently announced that their oral candidate for relapsing forms of multiple ...
-
November 19, 2012
Alnylam Pharmaceuticals, Inc. (ALNY) and Tekmira Pharmaceuticals Corporation recently signed a new licensing ...
-
November 16, 2012
We are reverting to a Neutral recommendation on Alkermes plc (ALKS) from Outperform as we believe that the stock is ...
